KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 120 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 1.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $14,000 | -6.7% | 4,000 | 0.0% | 0.00% | – |
| Q2 2018 | $15,000 | -11.8% | 4,000 | -6.3% | 0.00% | – |
| Q1 2018 | $17,000 | -15.0% | 4,269 | 0.0% | 0.00% | – |
| Q4 2017 | $20,000 | -67.2% | 4,269 | -50.6% | 0.00% | – |
| Q3 2017 | $61,000 | +3.4% | 8,635 | +6.4% | 0.00% | – |
| Q2 2017 | $59,000 | +31.1% | 8,118 | +10.9% | 0.00% | – |
| Q1 2017 | $45,000 | +95.7% | 7,319 | +83.0% | 0.00% | – |
| Q4 2016 | $23,000 | -14.8% | 4,000 | -20.0% | 0.00% | – |
| Q3 2016 | $27,000 | -37.2% | 5,000 | -23.1% | 0.00% | – |
| Q2 2016 | $43,000 | +43.3% | 6,500 | 0.0% | 0.00% | – |
| Q1 2016 | $30,000 | -41.2% | 6,500 | -35.0% | 0.00% | – |
| Q4 2015 | $51,000 | +30.8% | 10,001 | -9.1% | 0.00% | – |
| Q3 2015 | $39,000 | -98.2% | 11,001 | -94.9% | 0.00% | -100.0% |
| Q2 2015 | $2,165,000 | -22.1% | 216,945 | -0.7% | 0.00% | -33.3% |
| Q1 2015 | $2,780,000 | +27.9% | 218,414 | +42.1% | 0.00% | +50.0% |
| Q4 2014 | $2,174,000 | +2.9% | 153,674 | -0.0% | 0.00% | 0.0% |
| Q3 2014 | $2,113,000 | -43.4% | 153,678 | -36.7% | 0.00% | -50.0% |
| Q2 2014 | $3,733,000 | +75.2% | 242,737 | +94.1% | 0.00% | +33.3% |
| Q1 2014 | $2,131,000 | – | 125,046 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 1 | $3 | 0.00% |